PDT is an attractive method of treating skin cancers without surgery and with excellent results aesthetically, but its widespread implementation has been held up by high costs. The specialised light sources required were very expensive and could not be used for anything else. Swiss companies ave taken the lead in non-laser phototherapy and Q.Products AG makes the largest range of flexible and specialised non-laser devices. The flexible model for medical professionals who require a wide range of treatment options now has the capability to deliver the correct wavelengths of red, incoherent polarised light necessary to activate photosensitising creams such as Metvix® for PDT and also has a blue diagnosis filter which is used with a revealing cream to help identify lesions. There is also a new dedicated model for skin cancer specialists.
  Q.Light PRO

Q.Light PRO is a modular device using filter modules of different characteristics to treat a wide range of medical conditions.

With the new diagnosis and PDT treatment filter modules this reduces the cost of PDT equipment substantially, making treatments more viable financially.

• Diagnosis: blue light 385-450nm
• PDT Treament: red, incoherent polarised light, 620 - 780nm

Other optional filter modules allow phototherapy treatments of dermatological conditions, e.g.psoriasis and acne, acute or chronic wounds and further conditions (see pages from this web site).

Together these make Q.Light PRO a highly attractive and flexible device for dermatologists and skin cancer specialists with the capability of taking on new functions as required.
Choice of stands

Clinics, surgeries and practitioners operating in confined spaces can use the neat and sturdy Regular stand, with five casters for stability (with brakes for smooth floors), an adjustable arm and swivel ball joint for the head. This allows a great variety of positions and angles for the head whilst taking up very little valuable floor space.

Hospitals and larger clinics, especially those where over-bed use is desired will appreciate the PRO-Plus stand with extended cantilever arm and extra storage (additional lower shelf and storage basket not shown).

Product features
Polarised light radiation with power density of approx. 40 mW/cm² at maximum recommended treatment distance 40cm for most medical treatments, giving max. 40cm diameter coverage.

For PDT: 70mW/cm² (4.2J/cm²) at maximum recommended treatment distance 16.5cm with treatment diameter 16.5cm
Four aperture settings.
Inbuilt timer and multifunction display.
CE marked medical product, complying with Guidelines for Medical Products 9342 EWG and DIN EN ISO 13485:2003
Q.Light PDT

Q.Light PDT is a specialised model developed for skin cancer specialists and comes complete with the Diagnosis and PDT Treatment filter modules described above.

It can be used on the same choice of stands and also on the lightweight folding Home stand (see Q.Light Accessories page), however this is only recommended where portability is an important requirement. Q.Light PRO cannot be used on the Home stand.

Maximum treatment diameter 15cm.

Q.Light PDT has a simple on/off control.

 

Download the fact sheets for further information

Q.Light for Skin Cancer and PDT (features Q.Light PRO and includes Testimonials)
Q.Light for Psoriasis and Dermatitis (includes Treatment Guide)
Q.Light for Medical Professionals (includes Treatment Guide)
Q.Light PDT (in German only)
Overview of the Q.Light Range

The Q.Light® PRO is an attractive alternative to dedicated PDT light sources. The system and filter modules offer interchangeable diagnosis and treatment filters for PDT and a wide range of proven medical therapies using different light frequencies in a flexible and upgradable package.

Photodynamic Therapy [PDT] filter modules

PDT Diagnosis     Blue light 385-480nm for diagnosis.
PDT Treatment    Red incoherent polarised light 62-780nm: delivers 70mW/cm2 [4.2 J/cm2] at max treatment distance 16.5cm with treatment diameter 16.5cm.

The development of the PDT Treatment filter module has been based upon successful research into photodynamic therapy and,since 2004, upon clinical licensing from Metvix®. It has been
especially developed for Dermatologists and complies with regulations for medical products as set out in the Guidelines for Medical Products 93/42 EWG, also it has certification status based on the international standards and requirements for regulatory purposes of DIN EN ISO 13485:2003.

For optimal therapeutic effect a source of red, incoherent light is required (Szeimies et al. 1996; Fijan et al. 1995). Q.Light® PRO with the PDT Treatment filter module emits red, incoherent light in the spectrum from 620nm to 780nm. In accordance with the table below, this products light treatment times of between 13 and 45 minutes with the median time of approx. 25 min.

Indication Sensitiser Metvix® application Light dose Complete remission rate
 Actinic Keratosis  ALA and Metvix®  3 - 8 hours  60 - 150 J/cm2  71 - 100%
 Morbus Bowen (Bowends disease)  ALA and Metvix®  4 - 8 hours  80 - 180 J/cm2  90 - 100%
 Basal Cell Carcinoma (Superficial)  ALA and Metvix®  4 - 8 hours  100 - 180 J/cm2  80 - 95%
 Basal Cell Carcinoma (Knotted)  ALA and Metvix®  4 - 8 hours  100 - 180 J/cm2  20 - 60%

 

Indication for PDT in Dermatology:

Pre-cancerous   Actinic Keratosis
                         (also Arsen-inuzienrt)
                         Morbus Bowen
Tumours     Basal Cell Carcinoma
                  Gorlin-Goltz Syndrome
                  Initial spinozellulares Carcinoma

 

 


 

 

 

 

 

             

(c) Medilux Healthcare Limited. 2003 - 2009. All rights reserved
VAT No 887 9818 33      Comp Reg 5925249         Webmaster - Steven Warren s.warren@mediluxhealth.net.

Medilux Healthcare Limited is a specialised marketing company. We promote devices on the basis of the Manufacturers' representations as to quality and efficacy and where possible we provide additional information as to the conditions which may benefit from their use but we do not guarantee that they will be suitable or effective for all purchasers. We do not examine or diagnose patients or recommend treatments and where we promote medical services this is on an information-only basis. Patients contract directly with these providers and all clinical decisions are made by them alone.